Rezultati pretraživanja
  1. 30. ruj 2019.

    CARD study: cabazitaxel benefit independent of the previous NHT-Dox sequence. Even more subgroup analysis indicative that the caba benefit may apply to pts that received initial NHT for more than 12 months.

  2. 1. lis 2019.

    : Immunotherapy fails to improve PFS and OS in relapsed mesothelioma

  3. Day 2 at means the 2nd edition of the Reporter is now available. Missed your copy? Why not not check out the online version:

  4. 28. ruj 2019.

    calling human beings, mothers, fathers, siblings, sons, daughters we love dearly many of who did not survive "Test Subjects" is highly offensive even if you're just re-hashing other reports

    Prikaži ovu nit
  5. 4. lis 2019.

    ESMO19 Insights >>> Published by Roberto Alfaro in Twitter: RT : : Fake news in : how can address the issue

  6. 4. lis 2019.

    ESMO19 Insights >>> Published by HCC CONNECT in Twitter: RT : : bursts onto the biliary tract cancer scene

  7. 1. lis 2019.

    : INVICTUS trial - positive results for patients with GIST

  8. 1. pro 2019.

    is a continum debate on the accessibility and affordability of innovative medicines. B Jönsson discusses what is fair pricing in 👉

  9. 17. stu 2019.

    From : Are we reaching a turning point in metastatic ?

  10. 4. lis 2019.

    : Fake news in : how can address the issue

  11. 1. lis 2019.
  12. 29. ruj 2019.
  13. 28. ruj 2019.
  14. It's the first day of in today and our team of medical writers and designers are on site to deliver each edition of the Daily Reporter. Have you picked up your copy of today's edition yet? We'd love to know your thoughts...

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.